- Page 1 and 2:
National I
- Page 3 and 4:
ACKNOWLEDGMENT This monograph is ba
- Page 5 and 6:
Treatment Strategies for Volatile S
- Page 7 and 8:
extent of inhalant
- Page 9 and 10:
agencies. Dr. Carlini-Cotrim conclu
- Page 11 and 12:
prevalence, after alcohol and tobac
- Page 13 and 14:
Inhalant Use in th
- Page 15 and 16:
FIGURE 1. Lifetime prevalence for 1
- Page 17 and 18:
Reliability of the
- Page 19 and 20:
use beginning in 1987 when the surv
- Page 21 and 22:
TABLE 2. Current use of</st
- Page 23 and 24:
TABLE 3. Use of in
- Page 25 and 26:
TABLE 4. Inhalant
- Page 27 and 28:
TABLE 5. Lifetime prevalence and cu
- Page 29 and 30:
TABLE 7. Inhalant
- Page 31 and 32:
CONCLUSION Unlike other drugs in th
- Page 33 and 34:
AUTHORS Ruth W. Edwards, Ph.D. Rese
- Page 35 and 36:
Epidemiologic data were obtained fo
- Page 37 and 38:
perception of the
- Page 39 and 40:
Malaysia In Malaysia, the abuse <st
- Page 41 and 42:
The primary method of</stro
- Page 43 and 44:
them at least two to three times pe
- Page 45 and 46:
Curiosity is the most popular motiv
- Page 47 and 48:
Inhaling from a plastic bag: The vo
- Page 49 and 50:
(between US $0.04 and US $0.80) a d
- Page 51 and 52:
truant, who have money, and who are
- Page 53 and 54:
Edmondson, K. Review of</st
- Page 55 and 56:
Inhalant A
- Page 57 and 58:
Children working in the streets 280
- Page 59 and 60:
(1986), collected data on the preva
- Page 61 and 62:
Anecdotal information suggests that
- Page 63 and 64:
FIGURE 3. Psychological process mod
- Page 65 and 66:
ehavior. A secondary aim has been u
- Page 67 and 68:
REFERENCES ABC Communication. Consu
- Page 69 and 70:
Inhalant Use Among
- Page 71 and 72:
TABLE 1. Lifetime prevalence <stron
- Page 73 and 74:
TABLE 3. Lifetime prevalence <stron
- Page 75 and 76:
TABLE 4. Solvent use found for 1,83
- Page 77 and 78:
however, rarely is taken into consi
- Page 79 and 80:
TABLE 7. Weekly use (at least once
- Page 81 and 82:
TABLE 9. Use of dr
- Page 83 and 84:
Oetting, E.R.; Edwards, R.W.; and B
- Page 85 and 86:
RESULTS Prevalence Rates The findin
- Page 87 and 88:
TABLE 2. Use of in
- Page 89 and 90:
Incidence Rates Data from the surve
- Page 91 and 92:
TABLE 7. Use of in
- Page 93 and 94:
FIGURE 2(a). Proportion and number
- Page 95 and 96:
TABLE 8. Regression analysis: Use <
- Page 97 and 98:
TABLE 10(a). Mean age at first inha
- Page 99 and 100:
TABLE 13. Percentage of</st
- Page 101 and 102:
FIGURE 3. Opinion on health consequ
- Page 103 and 104:
The conduct of con
- Page 105 and 106:
Inhalant A
- Page 107 and 108:
The lack of epidem
- Page 109 and 110:
FIGURE 1. Substance abusers treated
- Page 111 and 112:
FIGURE 2. Drug used at initiation <
- Page 113 and 114:
The registered inhalant abusers ran
- Page 115 and 116:
medication, and jumping from a tall
- Page 117 and 118:
(with the main psychoactive compone
- Page 119 and 120:
In 1990, a World Health Organizatio
- Page 121 and 122:
FIGURE 7. Number of</strong
- Page 123 and 124:
of an epidemic, wh
- Page 125 and 126:
Oetting, E.R.; Beauvais, F.; and Ed
- Page 127 and 128:
FIGURE 1. Arrests for drug statute
- Page 129 and 130:
had inhaled the vapor from lacquer
- Page 131 and 132:
FIGURE 4. Numbers of</stron
- Page 133 and 134:
TABLE 3. Age appeared to consultati
- Page 135 and 136:
TABLE 5. Present occupational situa
- Page 137 and 138:
FIGURE 5. SOURCE: Longitudnal patte
- Page 139 and 140:
FIGURE 7. Longitudinal pattern <str
- Page 141 and 142:
Epidemiology <stro
- Page 143 and 144:
TABLE 1. National
- Page 145 and 146:
(Hughes et al. 1980). The system ha
- Page 147 and 148:
TABLE 2. National
- Page 149 and 150:
TABLE 3. National
- Page 151 and 152:
FIGURE 1. National
- Page 153 and 154:
FIGURE 3. Drug Registry System (SRI
- Page 155 and 156:
TABLE 5. National
- Page 157 and 158:
TABLE 6. National
- Page 159 and 160:
TABLE 7. National
- Page 161 and 162:
TABLE 9. National
- Page 163 and 164:
TABLE 9. National
- Page 165 and 166:
TABLE 10. National
- Page 167 and 168:
TABLE 10. National
- Page 169 and 170:
The longest running institution, th
- Page 171 and 172:
Several programs have been develope
- Page 173 and 174:
Thus, substance abuse research has
- Page 175 and 176:
3. Alcohol and tobacco were not con
- Page 177 and 178:
Leal, H., and Pacheco, G. Estrategi
- Page 179 and 180:
Division of <stron
- Page 181 and 182:
mind the fact that a sizeable numbe
- Page 183 and 184:
Adults and Older Students I
- Page 185 and 186:
Method Participants. Participants w
- Page 187 and 188:
TABLE 6. Types of
- Page 189 and 190:
TABLE 9. Sources of</strong
- Page 191 and 192:
THE NEED FOR MORE RESEARCH ON INHAL
- Page 193 and 194:
funding. However, by encouraging th
- Page 195 and 196:
AUTHOR Isidore Silas Obot, Ph.D., M
- Page 197 and 198:
abuse and their biomedical, social,
- Page 199 and 200:
nitrites—is virtually unknown in
- Page 201 and 202:
TABLE 3. Frequency of</stro
- Page 203 and 204:
TABLE 5. Lifetime prevalence and cu
- Page 205 and 206:
working with children living in the
- Page 207 and 208:
of the youthful po
- Page 209 and 210:
Lucchini, R. “Niños Callejeros y
- Page 211 and 212:
least as far back as 1983. However,
- Page 213 and 214:
TABLE 1. Phase-out schedule for ozo
- Page 215 and 216:
inquisitorial, unlike the procedure
- Page 217 and 218:
UNITED KINGDOM VSA-RELATED MORTALIT
- Page 219 and 220:
FIGURE 5. United Kingdom VSA-relate
- Page 221 and 222:
TABLE 2. United Kingdom VSA-related
- Page 223 and 224:
TABLE 4. United Kingdom VSA-related
- Page 225 and 226:
FIGURE 6. United Kingdom VSA-relate
- Page 227 and 228:
FIGURE 9. United Kingdom VSA-relate
- Page 229 and 230:
NATIONAL VSA STATISTICS The only <s
- Page 231 and 232:
TABLE 6. National
- Page 233 and 234:
TABLE 7. Local surveys giving infor
- Page 235 and 236:
TABLE 7. Local surveys giving infor
- Page 237 and 238:
presented as a confidential “Scho
- Page 239 and 240:
TABLE 8. Surveys of</strong
- Page 241 and 242:
Children’s Act 1989: Section 17 r
- Page 243 and 244:
problem would go away like other te
- Page 245 and 246:
Children ages 14-16 “should have
- Page 247 and 248:
contributions from many small group
- Page 249 and 250:
Chadwick, O.; Anderson, R.; Bland,
- Page 251 and 252:
Market and Opinion Research Interna
- Page 253 and 254:
Streete, P.J.; Ruprah, M.; Ramsey,
- Page 255 and 256:
Treatment Strategies for Volatile S
- Page 257 and 258:
that they chose solvents not only b
- Page 259 and 260:
Medical management and detoxificati
- Page 261 and 262:
challenges to a healthy readjustmen
- Page 263 and 264:
REFERENCES Beauvais, F. Social and
- Page 265 and 266: Gathering Epidemiologic Information
- Page 267 and 268: DIRECT POPULATION SURVEYS Cross-sec
- Page 269 and 270: The findings in the two surveys wer
- Page 271 and 272: TABLE 1. Recent use a of</s
- Page 273 and 274: are due to the fact that inhalants
- Page 275 and 276: number usually is advertised in tel
- Page 277 and 278: REFERENCES Beauvais, F. Volatile so
- Page 279 and 280: Inhalants: A Polic
- Page 281 and 282: predominated, but it seems clear th
- Page 283 and 284: classes containing these substances
- Page 285 and 286: justify their positions more on pri
- Page 287 and 288: eformulation of pr
- Page 289 and 290: with abuse potential, and additiona
- Page 291 and 292: TABLE 2. Type of l
- Page 293 and 294: TABLE 3. Type of d
- Page 295 and 296: TABLE 4. Type of b
- Page 297 and 298: TABLE 5. Specified products regulat
- Page 299 and 300: TABLE 6. Prevention curricula and i
- Page 301 and 302: appear to enter treatment that prog
- Page 303 and 304: Policy Alternative 1: Change Produc
- Page 305 and 306: outcome evaluations. Ideally, such
- Page 307 and 308: Mata, A.G., Jr., and Andrew, S.R. <
- Page 309 and 310: Recommendations and Conclusions Zil
- Page 311 and 312: AUTHORS Zili Sloboda, Sc.D. Nichola
- Page 313 and 314: 26 42 50 52 53 54 56 61 62 THE BEHA
- Page 315: 80 82 83 84 85 87 88 89 92 NEEDLE S
- Page 319 and 320: 124 NEUROBIOLOGICAL APPROACHES TO B
- Page 321 and 322: 138 139 140 141 142 143 IMAGING TEC
- Page 323: NIH Publication No 95-3831 Printed